BSE filing, NSE: CHEMCRUX. Summary written from the filing by ALFA Finder's alert engine.
Chemcrux Enterprises Ltd: key numbers
- Share price
- ₹82.20
- Market cap
- ₹121.7 Cr
- Revenue (annual)
- ₹80.65 Cr
- Net profit (annual)
- ₹3.73 Cr
- P/E (TTM)
- 29.4×Sector 34.1×
- Promoter holding
- 72.92%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chemcrux Enterprises Ltd
All →Chemcrux Enterprises Board Meeting Date
Chemcrux Enterprises intimated a Board Meeting scheduled for 02 November 2026 to approve unaudited financial results for Q2 and H1 FY2026-27. The trading window for insiders remains closed until 48 hours after results are published.
Chemcrux Enterprises Other Announcement
Chemcrux Enterprises Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This disclosure provides details on the company's equity structure and stakeholder ownership.
Chemcrux Enterprises Annual General Meeting
Chemcrux Enterprises held its 30th Annual General Meeting on September 17, 2026. The meeting covered routine business, including financial statement approval and dividend declaration.
Chemcrux Enterprises Management Change
Mr. Bhanubhai Patel and Mr. Shailesh Patel have ceased to be Independent Directors of the Company following the completion of their second five-year tenure.
Chemcrux Enterprises Dividend
Chemcrux Enterprises Limited recommended a final dividend of Re. 1 per equity share for FY 2025-26. The payment follows the upcoming General Meeting.
Chemcrux Enterprises Other Announcement
Chemcrux Enterprises has fixed 10th September 2026 as the record date to ascertain eligibility for the final dividend to be declared at the 30th AGM.
Other management change announcements
All →iStreet Network Management Change
iStreet Network Ltd announced the resignation of Non-Executive Non-Independent Director Mr. Yash Maheshwari effective 13 October 2026. No financial impact is indicated.
Transgene Biotek Management Change
Transgene Biotek's statutory auditors Eswara Rao & Co. resigned effective 28 October 2026 citing pre-occupation. The company will appoint new auditors per applicable regulations.
Mobavenue AI Tech Management Change
Mobavenue AI Tech appointed Vikram Sheth as Chief of Corporate Development and Investor Relations. He will lead fundraising, acquisitions and investor relations.
Hexaware Technologies Management Change
Hexaware appointed Arjun Shah and Gregory Zeluck as Non-Executive Directors from 28 October 2026. Directors Neeraj Bharadwaj and Julius Genachowski resigned, and Girish Pai's resignation is effective 13 November 2026.
GMR Airports Management Change
GMR Airports appointed Sanjeev Gupta as Executive Director (Deputy CEO) effective 29 October 2026. Non-Executive Director Alexis Riols resigned effective 28 October 2026.
Raymond Realty Management Change
Raymond Realty said joint statutory auditor Chaturvedi & Shah LLP resigned on 28 October 2026 after a dispute over audit fee revision. Walker Chandiok & Co LLP continues as the other statutory auditor.